Emergent Biosolutions Inc. (EBS) Lobbying Data
EBS lobbying summary
Emergent Biosolutions Inc. (EBS) has reported $27.2M in federal lobbying spending across 249 Senate LDA filings since 2020. Its most frequent lobbying issues are Health Issues, Budget/Appropriations, Disaster Planning, Homeland Security. Lobbying firms used include The Nickles Group, LLC, Emergent Biosolutions Inc., Alpine Group Partners, LLC..
Lobbying spending by year
| Year | Reported spend |
|---|---|
| 2026 | $2.1M |
| 2025 | $3.1M |
| 2024 | $3.7M |
| 2023 | $4.2M |
| 2022 | $4.2M |
| 2021 | $4.8M |
See insider trading for EBS or the Lobbying Heavyweights strategy.
Source: Senate Lobbying Disclosure Act (LD-2) filings. The current year is partial.